Our current site no longer reflects the calibre of work we do in diabetes and obesity drug development. I want to bring it up to the same polished, investor-ready standard that Oramed Inc. demonstrates, while keeping our own voice and scientific strengths front and centre. Scope • Re-think the entire visual design so it feels clean, modern and clinically credible. • Restructure the content flow to put Great Science, Safety, patent strengths and solid Clinical Data in clear focus, with intuitive navigation for both investors and HCPs. • Build in interactive elements—animated data charts, hover-state explanations, a timeline of trial milestones and a dynamic news feed—to keep visitors engaged and informed. • Integrate a freshly designed logo and colour scheme so the branding is consistent across every page. Key pages Home, Pipeline, Mechanism of Action, Clinical Results, Safety, Publications, Investors, Newsroom and Contact—each needs a flexible template so new studies or press releases can be added without code changes. Tech preferences A responsive stack (WordPress or similar CMS, HTML5, CSS3, JavaScript, possibly Bootstrap) that plays well with Google Analytics and basic SEO. All graphics should ship optimised for fast load times and retina displays. Deliverables 1. High-fidelity mock-ups for desktop, tablet and mobile. 2. Fully developed theme and page templates. 3. Migration of existing content, rewritten where necessary for clarity and SEO. 4. One-click staging environment, plus deployment instructions. Acceptance criteria • Pages load in <2 s on a standard 4G connection. • All interactive elements function across Chrome, Safari, Edge and Firefox. • Core Web Vitals pass green on PageSpeed Insights. • Final site mirrors Oramed-level polish while clearly communicating our science, safety profile and clinical efficacy.